Skip to main content
. 2022 Jan 25;13:214–223. doi: 10.18632/oncotarget.28182

Table 4. Effect of carvedilol on galectin-3 and myeloperoxidase.

Placebo Carvedilol P value
N = 148 N = 26
Galectin 3 ng/ml 0.32
 Baseline 6.3 (5.2–9.2) 6.4 (5.1, 10.8)
 12 weeks 11.8 (10.2–15.9) 12.9 (9.1, 16.2)
 24 weeks 11.2 (8.4–12.8) 10.3 (7.5–13.1)
Myeloperoxidase ng/ml 0.28
 Baseline 13.3 (7.6–21.0) 13.2 (8.5–29.2)
 12 weeks 15.3 (11.0–25.5) 20.9 (11.2–39.1)
 24 weeks 19.6 (11.9–37.7) 19.2 (10.6–43.7)